Home / Anti-infectives / Papillomavirus (human types 16, 18)
ATC J07BM02 · Papillomavirus Vaccines · updated 4 Nov 2026
Papillomavirus (human types 16, 18) shortage
As of 4 Nov 2026, Papillomavirus (human types 16, 18) has a reported shortage in 1 of the 16 countries we track (Canada), covering 1 product from 1 company.
Is there a Papillomavirus (human types 16, 18) shortage?
Yes. As of 4 Nov 2026, Papillomavirus (human types 16, 18) is reported short in 1 of the 16 countries we track: Canada. The earliest expected return is 21 Dec 2026 (Canada).
Which companies are short
products short, all countriesListed: GSK GSK · LSE
Affected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | CERVARIX (All pack sizes / Tous les formats) discontinuation | GLAXOSMITHKLINE INC | not given | 21 Dec 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Papillomavirus (human types 16, 18) shortage?
Yes. As of 4 Nov 2026, Papillomavirus (human types 16, 18) is reported short in 1 of the 16 countries we track: Canada. The earliest expected return is 21 Dec 2026 (Canada).
When will Papillomavirus (human types 16, 18) be back in stock?
Companies expect supply back from 21 Dec 2026 in Canada; Canada: 21 Dec 2026. These are company estimates reported to each authority.
Why is Papillomavirus (human types 16, 18) in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Papillomavirus (human types 16, 18) shortages?
GSK.